LIGHT-UP outcomes: GS200 patients lose on average 11% of body weight
Results from the LIGHT-UP clinical trial for adults with overweight or obesity who have prediabetes or type 2 diabetes and were treated...
top of page
Browse by category
Search
Gelesis announces merger with Capstar Special
Gelesis, a biotherapeutics company advancing biomimetic superabsorbent hydrogels to treat excess weight and metabolic disorders, and...
Plenity induced weight loss results in NALFD fibrosis score improvement
A post-hoc analysis showed that treatment for weight management with Plenity decreased a marker for liver fibrosis (the NAFLD fibrosis...
Gelesis gains European approval for PLENITY weight loss treatment
Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to...
Browse by tag
bottom of page